6.
Yan G, Hua S, Li J
. Categorization of 34 computational methods to detect spatially variable genes from spatially resolved transcriptomics data. Nat Commun. 2025; 16(1):1141.
PMC: 11779979.
DOI: 10.1038/s41467-025-56080-w.
View
7.
Liang P, Zhang J, Wu Y, Zheng S, Xu Z, Yang S
. An ULK1/2-PXN mechanotransduction pathway suppresses breast cancer cell migration. EMBO Rep. 2023; 24(11):e56850.
PMC: 10626438.
DOI: 10.15252/embr.202356850.
View
8.
Li D, Li Y, Wu X, Li Q, Yu J, Gen J
. Knockdown of Mgat5 inhibits breast cancer cell growth with activation of CD4+ T cells and macrophages. J Immunol. 2008; 180(5):3158-65.
DOI: 10.4049/jimmunol.180.5.3158.
View
9.
Xu Z, Li X, Li H, Nie C, Liu W, Li S
. Suppression of DDX39B sensitizes ovarian cancer cells to DNA-damaging chemotherapeutic agents via destabilizing BRCA1 mRNA. Oncogene. 2020; 39(47):7051-7062.
DOI: 10.1038/s41388-020-01482-x.
View
10.
Marrufo A, Mathew S, Chaudhary P, Malaer J, Vishwanatha J, Mathew P
. Blocking LLT1 (CLEC2D, OCIL)-NKRP1A (CD161) interaction enhances natural killer cell-mediated lysis of triple-negative breast cancer cells. Am J Cancer Res. 2018; 8(6):1050-1063.
PMC: 6048397.
View
11.
Zappia L, Phipson B, Oshlack A
. Splatter: simulation of single-cell RNA sequencing data. Genome Biol. 2017; 18(1):174.
PMC: 5596896.
DOI: 10.1186/s13059-017-1305-0.
View
12.
Salem Y, Yacov N, Propheta-Meiran O, Breitbart E, Mendel I
. Newly characterized motile sperm domain-containing protein 2 promotes human breast cancer metastasis. Int J Cancer. 2018; 144(1):125-135.
PMC: 6588022.
DOI: 10.1002/ijc.31665.
View
13.
Zhang J, Li Y, Wang J, Feng J, Huang G, Luo C
. Dihydroartemisinin Affects STAT3/DDA1 Signaling Pathway and Reverses Breast Cancer Resistance to Cisplatin. Am J Chin Med. 2023; 51(2):445-459.
DOI: 10.1142/S0192415X23500234.
View
14.
Chen X, Peng H, Zhang Z, Yang C, Liu Y, Chen Y
. SPDYC serves as a prognostic biomarker related to lipid metabolism and the immune microenvironment in breast cancer. Immunol Res. 2024; 72(5):1030-1050.
DOI: 10.1007/s12026-024-09505-5.
View
15.
Zhu D, Zhao Z, Cui G, Chang S, Hu L, See Y
. Single-Cell Transcriptome Analysis Reveals Estrogen Signaling Coordinately Augments One-Carbon, Polyamine, and Purine Synthesis in Breast Cancer. Cell Rep. 2018; 25(8):2285-2298.e4.
DOI: 10.1016/j.celrep.2018.10.093.
View
16.
Camp N, Parry M, Knight S, Abo R, Elliott G, Rigas S
. Fine-mapping CASP8 risk variants in breast cancer. Cancer Epidemiol Biomarkers Prev. 2011; 21(1):176-81.
PMC: 3253962.
DOI: 10.1158/1055-9965.EPI-11-0845.
View
17.
Mondal M, Conole D, Nautiyal J, Tate E
. UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology. Br J Cancer. 2021; 126(1):24-33.
PMC: 8727673.
DOI: 10.1038/s41416-021-01516-5.
View
18.
Townes F, Hicks S, Aryee M, Irizarry R
. Feature selection and dimension reduction for single-cell RNA-Seq based on a multinomial model. Genome Biol. 2019; 20(1):295.
PMC: 6927135.
DOI: 10.1186/s13059-019-1861-6.
View
19.
Wang J, Dean D, Hornicek F, Shi H, Duan Z
. Cyclin-dependent kinase 9 (CDK9) is a novel prognostic marker and therapeutic target in ovarian cancer. FASEB J. 2019; 33(5):5990-6000.
PMC: 6463912.
DOI: 10.1096/fj.201801789RR.
View
20.
Abrar M, Kaykobad M, Rahman M, Hassan Samee M
. NoVaTeST: identifying genes with location-dependent noise variance in spatial transcriptomics data. Bioinformatics. 2023; 39(6).
PMC: 10283152.
DOI: 10.1093/bioinformatics/btad372.
View